补充描述:
KBI Biopharma provides full-cycle process development for both mammalian and microbial biologics, guiding projects from early feasibility and small-scale protein production through upstream and downstream optimization, characterization, and scale-down validation toward robust cGMP transfer. Drawing on CHO and E. coli platform expertise, the company tailors solutions to molecule-specific challenges while shortening development timelines, aiming to deliver high-yield, high-quality, GMP- and regulator-ready processes whether refining existing methods or building new ones.
留下您的评分和评论